CRC Scheduling
Schedule a CRC Visit
CRC Calendar
Pediatric CRC Scheduling
Schedule a Pediatric
CRC Visit
Pediatric CRC Calendar
| |
|
|
NIH News National Institutes of Health (NIH) News Releases
News Releases from the National Institutes of Health (NIH)
NHLBI Stops Enrollment in Study on Resuscitation Methods for Cardiac ArrestEnrollment has ended early in a large, multicenter clinical trial
comparing two distinct resuscitation strategies delivered by emergency
medical service (EMS) providers to increase blood flow during cardiac
arrest. The study's independent monitoring board and the National
Heart, Lung, and Blood Institute (NHLBI), the lead sponsor of the
study, stopped enrollment based on preliminary data suggesting
that neither strategy significantly improved survival. One strategy
compared different durations of manual cardiopulmonary resuscitation
(CPR) by EMS providers before they assessed whether defibrillation
was needed, and the other strategy tested the potential benefits
and risks of an investigational device to maintain pressure in
the chest during CPR. |
NIDA Launches New Substance Abuse Resources to Help Fill Gaps in Medical EducationThe rigors of medical training sharpen a doctor's ability to diagnose and
treat a wide variety of human afflictions. However, drug abuse and addiction
are often insufficiently covered in medical school curricula, despite the fact
that drug use affects a wide range of health conditions and drug abuse and
addiction are themselves major public health issues. |
What Can Prevent Walking Disability in Older People?
The National Institute on Aging (NIA), part of the National Institutes of Health, today announced the award of $29.5 million in grant support over the next two years to determine whether a specific physical activity program can stave off disability in older people. The funding will begin the Lifestyle Interventions and Independence for Elders — LIFE — trial, the largest ever undertaken to prevent mobility disability among older people who are at risk of losing their ability to walk and to live independently in the community. The grant is being awarded to the University of Florida’s Institute on Aging in Gainesville.
|
NIAID Awards Five-Year, $56 Million Contract to Continue Study of Asthma in Inner City Children The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has renewed the contract to continue studying asthma in children living in lower-income, inner city environments. This five-year, $56 million award will support the Inner-City Asthma Consortium (ICAC), a nationwide clinical trials network to evaluate promising new therapies to reduce asthma severity and prevent disease, and to perform basic research to understand how these therapies work. |
NIH-Supported Trial to Study Testosterone Therapy in Older MenLow serum testosterone may contribute to a number of problems affecting older men, including decreased ability to walk, loss of muscle mass and strength, decreased vitality, decreased sexual function, impaired cognition, cardiovascular disease and anemia. While testosterone normally decreases with age, in some men, low levels of testosterone may contribute to these debilitating conditions. A new national clinical trial will test whether these conditions can be favorably affected by testosterone therapy. |
NIH Awards $27 Million in Recovery Act Funds to Enhance Scientist and Resource NetworkingThe National Institutes of Health (NIH) today announced awards that will harness the power of social networking to help scientists and students throughout the country accelerate biomedical research. The same principles and technology that enable teenagers to instantly share updates and pictures with their friends also can help researchers connect, collaborate and share resources better and faster on scientific advances. All software developed in this project will be freely available to biomedical institutions in the non-profit sector. |
Clinical Tests Begin on Medication to Correct Fragile X DefectNIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile X syndrome, the most common inherited cause of intellectual disability. There has to date been no medication that could alter the disorder's neurologic abnormalities. The study will evaluate safety, tolerability, and optimal dosage in healthy volunteers. |
Researchers Develop Innovative Imaging System to Study Sudden Cardiac Arrest A research team at Vanderbilt University has developed an innovative optical system to simultaneously image electrical activity and metabolic properties in the same region of a heart, to study the complex mechanisms that lead to sudden cardiac arrest. Tested in animal models, the system could dramatically advance scientists' understanding of the relationship between metabolic disorders and heart rhythm disturbances in humans that can lead to cardiac arrest and death, and provide a platform for testing new treatments to prevent or stop potentially fatal irregular heartbeats, known as arrhythmias. |
NIH Launches Multicenter Clinical Trial to Test Blood Pressure StrategyThe National Institutes of Health is launching a large multicenter randomized clinical trial to determine whether maintaining blood pressure levels lower than current recommendations further reduces the risk of cardiovascular and kidney diseases, or age-related cognitive decline. Called the Systolic Blood Pressure Intervention Trial (SPRINT), the nine-year, $114 million study will be conducted in more than 80 clinical sites across the United States. |
NIAID Scientists Propose New Explanation for Flu Virus Antigenic DriftInfluenza viruses evade infection-fighting antibodies by constantly changing the shape of their major surface protein. This shape-shifting, called antigenic drift, is why influenza vaccines — which are designed to elicit antibodies matched to each year's circulating virus strains — must be reformulated annually. Now, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have proposed a new explanation for the evolutionary forces that drive antigenic drift. The findings in mice, using a strain of seasonal influenza virus first isolated in 1934, also suggest that antigenic drift might be slowed by increasing the number of children vaccinated against influenza. |
Federal Stimulus Grant Supports Crucial Study of Anti-Nicotine VaccineEfforts to develop a vaccine capable of preventing tobacco addiction got a $10-million shot in the arm in the form of an American Recovery and Reinvestment Act grant. The award to Nabi Biopharmaceuticals of Rockville, Md., was funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. |
NIH Awards $75 Million for Research in Minority InstitutionsThe National Center for Research Resources (NCRR), part of the National Institutes of Health, announced today that it will provide approximately $75 million over the next five years to support four institutions via NCRR's Research Centers in Minority Institutions (RCMIs) program. The RCMI program enhances research capacity and infrastructure in minority institutions. Three of the four institutions will receive funding through a new program, the RCMI Infrastructure for Clinical and Translational Research (RCTR). The fourth grant establishes a new RCMI center at Xavier University of Louisiana. |
NIA Extends Research on Health, Economics of Older AmericansThe National Institute on Aging (NIA), part of the National Institutes of Health, today announced the award of four grants totaling more than $19 million over the next two years to expand the Health and Retirement Study (HRS), the nation's premier long-term study and data resource on the combined health, economic, and social factors influencing the well-being of Americans over age 50. |
A Decade Later, Lifestyle Changes or Metformin Still Lower Type 2 Diabetes RiskIntensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent compared with placebo in people at high risk for the disease, researchers conclude based on 10 years of data.
Participants randomly assigned to make lifestyle changes also had more favorable cardiovascular risk factors, including lower blood pressure and triglyceride levels, despite taking fewer drugs to control their heart disease risk, according to the study. |
NIH-Funded Researchers Transform Embryonic Stem Cells Into Human Germ Cells Researchers funded in part by the National Institutes of Health
have discovered how to transform human embryonic stem cells into
germ cells, the embryonic cells that ultimately give rise to
sperm and eggs. The advance will allow researchers to observe
human germ cells -- previously inaccessible -- in laboratory dishes. |
NIEHS Awards Recovery Act Funds to Address Bisphenol A Research GapsResearchers studying the health effects of the chemical bisphenol A (BPA) gathered in North Carolina to launch an integrated research initiative to produce data that will allow for a comprehensive assessment of its possible human health effects. Researchers who just received funds from the American Recovery and Reinvestment Act to study BPA were brought together to meet with scientists from academia and government already working on the compound. The meeting was held Oct. 6, 2009 at the National Institute of Environmental Health Sciences (NIEHS). |
Recovery Act Funds Expand Studies of Stem Cell BiologyThe National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health, is using $5.4 million of Recovery Act funds to accelerate basic studies of induced pluripotent stem cells. These cells, abbreviated iPS, are reprogrammed from skin or other easily obtained adult cells and appear to be similar to stem cells derived from embryos. |
New EUREKA Awards Fund Highly Innovative Research, Promise Big PayoffsThe National Institutes of Health has awarded 56 grants of up to $67.4 million to support highly innovative research projects that promise big scientific payoffs. The new awards are part of the EUREKA (Exceptional, Unconventional Research Enabling Knowledge Acceleration) program, which helps scientists test new, unconventional ideas or tackle major methodological or technical challenges. |
A Call to Copenhagen -- Health Effects of Climate ChangeMembers of the press are invited to the unveiling
and policy discussion of a major international study on the
Public Health Impacts of Reducing Greenhouse Gas Emissions
being published in Lancet, just in time for the upcoming
United Nations Climate Change Conference in Copenhagen. The
National Institute of Environmental Health Sciences (NIEHS),
one of the National Institutes of Health, is sponsoring the
event which will feature speakers from around the world gathered
in Washington, DC and at the London School of Hygiene and
Tropical Medicine participating via live video conferencing. |
Clinical Research Fellows Learn About Options and OpportunitiesMore than 270 medical and dental students from 70 U.S. schools will be at the National Institutes of Health Clinical Center next month for the seventh-annual Clinical Investigator Student Trainee Forum. The students, who represent the next generation of clinician-scientists, will have the opportunity to learn more about new medical research methods and technologies and to network with established clinical and translational researchers. |
|
